Cargando…
Dihydroberberine exhibits synergistic effects with sunitinib on NSCLC NCI‐H460 cells by repressing MAP kinase pathways and inflammatory mediators
Highly effective and attenuated dose schedules are good regimens for drug research and development. Combination chemotherapy is a good strategy in cancer therapy. We evaluated the antitumour effects of dihydroberberine combined with sunitinib (DCS) on the human non‐small cell lung cancer cell lines...
Autores principales: | Dai, Bingling, Ma, Yujiao, Wang, Wenjie, Zhan, Yingzhuan, Zhang, Dongdong, Liu, Rui, Zhang, Yanmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618684/ https://www.ncbi.nlm.nih.gov/pubmed/28444871 http://dx.doi.org/10.1111/jcmm.13178 |
Ejemplares similares
-
Synthesis of new dihydroberberine and tetrahydroberberine analogues and evaluation of their antiproliferative activity on NCI-H1975 cells
por: Mari, Giacomo, et al.
Publicado: (2020) -
A novel tissue model for angiogenesis: evaluation of inhibitors or promoters in tissue level
por: Dai, Bingling, et al.
Publicado: (2014) -
Metformin synergistically enhances antiproliferative
effects of cisplatin and etoposide in NCI-H460 human lung cancer cells
por: Teixeira, Sarah Fernandes, et al.
Publicado: (2013) -
Eupolyphaga sinensis Walker displays inhibition on hepatocellular carcinoma through regulating cell growth and metastasis signaling
por: Zhang, Yanmin, et al.
Publicado: (2014) -
Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine
por: Buchanan, Beth, et al.
Publicado: (2018)